11th Jan 2005 07:00
Advanced Medical Solutions Grp PLC11 January 2005 For Immediate Release 11 January 2005 Advanced Medical Solutions Group plc ("AMS" or "the Company") Pre-close trading update Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the global woundcare technology company, is pleased to update investors on trading ahead of theclose period for the year ending 31st December 2004. Dr. Geoffrey Vernon, Chairman of AMS, stated: "The progress reported at the halfyear in growing revenues and reducing losses has continued during the secondhalf of 2004. "The outlook remains positive, particularly following further expansion of theCompany's routes to market with its recently announced inclusion in the NHSFramework Agreement for Advanced Woundcare in England "The Company continues to trade in line with market expectations and remainsfirmly on track to come through to profitability within current cash." For further information, please contact: Advanced Medical Solutions Group plc Tel : +44 (0) 1606 545508Don Evans, Chief ExecutiveMary Tavener, Finance Directorwww.admedsol.com Buchanan Communications Tel: +44 (0) 20 7466 5000Mark Court, Mary-Jane Johnson Notes to Editors: Advanced Medical Solutions is a leading company in the development andmanufacture of products for the $15 billion global woundcare market. Founded in 1991 and currently quoted on AIM, Advanced Medical Solutions isfocused on the design, development and manufacture of innovative andtechnologically advanced products for woundcare and other medical applications. In-house natural and synthetic polymer technology is used to provide advancedwound dressings based on the moist healing principle. AMS's resources ensure aunique position as a vertically integrated 'one stop shop' to provide allcategories of moist wound healing products. The Company has the capability tomove from product design and development through to production and deliveryready for distribution into customer markets. The acquisition of MedLogic in 2002 has brought AMS products and technology incyanoacrylate based tissue adhesives and sealants sold direct to hospitals orthrough distributors. AMS's technology and products currently serve the majority of the key globalmarkets with strategic partners including 3M, Novartis, Johnson & Johnson,Molnlycke Healthcare, Smith + Nephew and Cardinal. This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Advanced Medical Solutions Group